Postpartum Diabetes Management
For women with gestational diabetes, discontinue all glucose-lowering medications immediately after delivery and monitor blood glucose for 24-72 hours; for women with pre-gestational type 1 diabetes, resume basal-bolus insulin at 50-80% of pre-pregnancy doses or 50% of end-pregnancy doses immediately after stopping any intravenous insulin; for women with pre-gestational type 2 diabetes, continue insulin at half-dose pending endocrinology consultation. 1, 2
Immediate Postpartum Period (First 24-72 Hours)
Gestational Diabetes
- Stop all insulin and oral medications immediately after delivery unless overt diabetes is suspected 2, 1, 2
- Monitor blood glucose before meals and 2 hours postprandially for 24-72 hours 2, 1
- Target glucose range: 6-8.8 mmol/L (108-158 mg/dL) after vaginal delivery; slightly lower after cesarean section to support wound healing 1
- If fasting glucose >7 mmol/L (126 mg/dL) or postprandial >11 mmol/L (198 mg/dL), consult endocrinology for possible continuation of therapy 1
Pre-gestational Type 1 Diabetes
- Never stop basal insulin - risk of diabetic ketoacidosis 1
- Resume basal-bolus regimen at either:
- 80% of pre-pregnancy doses, OR
- 50% of end-pregnancy doses 1
- If on insulin pump, restart immediately when IV insulin is discontinued 1
- If last basal injection was >24 hours ago, administer immediately 1
- Postpartum insulin sensitivity is dramatically enhanced compared to pregnancy, requiring close monitoring to prevent hypoglycemia 3
Pre-gestational Type 2 Diabetes
- Continue insulin at 50% of pregnancy dose while awaiting endocrinology consultation 1
- Consider restarting oral agents only if not breastfeeding 1
Follow-up Testing (6-12 Weeks Postpartum)
For Women with Gestational Diabetes
Perform a 75-gram, 2-hour oral glucose tolerance test (OGTT) at 6-12 weeks postpartum to rule out prediabetes or diabetes 2, 4, 2
- Use non-pregnant diagnostic criteria for interpretation 4
- If OGTT is normal at 6-12 weeks, repeat diabetes screening at least every 3 years (or annually with HbA1c) 4
- Alternative: Fasting plasma glucose at 6 weeks OR HbA1c at 13 weeks if OGTT not feasible 5
- Do not use HbA1c immediately postpartum - may still be affected by pregnancy-related red cell turnover and peripartum blood loss 4
For Women with Pre-gestational Diabetes
- Resume standard diabetes monitoring and management
- Adjust medications based on breastfeeding status and glucose control
- Screen for and manage any pregnancy-related complications (retinopathy progression, nephropathy)
Long-term Management and Counseling
Lifestyle Interventions (All Women)
Provide intensive counseling on lifestyle modifications to reduce type 2 diabetes risk 2:
- Medical nutrition therapy
- Daily moderate exercise for 30+ minutes
- Weight management strategies
- Breastfeeding encouragement (increases insulin sensitivity and aids weight loss) 3
Ongoing Surveillance
- Women with prior GDM have 50-60% cumulative risk of developing type 2 diabetes 4
- Screen before any future pregnancies 2
- Document GDM history and infant birth weight in child's permanent medical record 2
Contraception Planning
Discuss and prescribe long-acting reversible contraception before hospital discharge 6
- Essential for appropriate pregnancy planning
- Allows optimization of glycemic control before next conception
- Prevents unintended pregnancies with associated risks
Breastfeeding Considerations
Benefits
- Maternal: Increased insulin sensitivity, weight loss, reduced future diabetes risk
- Infant: Reduced risk of childhood obesity and type 2 diabetes 3
Glucose Management During Lactation
- Breastfeeding increases insulin sensitivity and glucose utilization
- May require further insulin dose reductions
- Monitor for hypoglycemia, especially during and after nursing
- Ensure adequate carbohydrate intake to prevent hypoglycemia
Medication Safety
- Insulin is safe during breastfeeding (all types)
- Metformin may be considered in type 2 diabetes if not contraindicated
- Avoid most other oral agents during breastfeeding 1
Critical Pitfalls to Avoid
- Never discontinue basal insulin in type 1 diabetes - even briefly increases ketoacidosis risk 1
- Do not use HbA1c for immediate postpartum diabetes screening in GDM - wait until 13 weeks or use OGTT at 6-12 weeks 4
- Do not assume GDM has resolved - 5-10% may have persistent diabetes requiring ongoing treatment 2
- Do not forget to reduce insulin doses in pre-gestational diabetes - pregnancy insulin requirements are 2-3 times higher than postpartum needs 1, 3
- Do not miss the 6-12 week follow-up window - this is when definitive testing should occur before the opportunity is lost 2, 4, 2